-
Assessing the Impact of Technology-Powered, Pharmacy- and Nursing-Supported Direct Oral Anticoagulant Management
Sep 9, 2025, 16:22 PM -
AI Time and Motion - Analysis of the Accuracy and Efficiency of AI for HTA-Standard SLRs
Sep 9, 2025, 16:22 PM -
Understanding the Impact of Equality and Equity Considerations on NICE Highly Specialized Technology (HST) Decision Making
Sep 9, 2025, 16:22 PM -
Evaluating the Digital Transformation in Healthcare: Adoption, Challenges, and Opportunities
Sep 9, 2025, 16:22 PM -
The Safety and Effectiveness of Drug-Induced Sleep Endoscopy in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Exploring Beyond the Gut: A Qualitative Study of Extraintestinal Symptoms in Ulcerative Colitis and Crohn's Disease
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Genetic Testing for Optimizing Warfarin Therapy in Mechanical Heart Valve Patients: Insights From Qatar
Sep 9, 2025, 16:22 PM -
Design, Implementation, Data Analysis on the Time-Motions Studies: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)
Sep 9, 2025, 16:22 PM -
Bridging the Gap: Why Cost-Effectiveness Analyses of Congenital Heart Interventions Are Critical for Person-Centered Value-Based Care
Sep 9, 2025, 16:22 PM -
extRpolateS: A Shiny-Based Interactive Platform for Time-to-Event Data Modeling in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
The Economic Burden of Amyotrophic Lateral Sclerosis: An Observational Study of Out-of-Pocket Expenses and the Impact on Caregivers
Sep 9, 2025, 16:22 PM -
Modeling the Lifetime Effects of Lecanemab in Early Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals
Sep 9, 2025, 16:22 PM -
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization (HCRU) and Associated Costs in Patients With Advanced Merkel Cell Carcinoma (aMCC) in Germany: Analysis From the MCC TRIM Registry Study
Sep 9, 2025, 16:22 PM -
Real-World Assessment Process to Identify Fit-for-Purpose Data Sources to Meet Milestones for Post-Marketing Requirements (PMR), Post Authorization Safety Studies (PASS), and Health Technology Assessment (HTA) Submissions Utilizing Source Exploration...
Sep 9, 2025, 16:22 PM -
Estimating the Broader Societal Impact of Ocrelizumab for Multiple Sclerosis (MS) in Latin America (LATAM) Using a Social Impact Approach
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire Item-10 (Physical Fatigue) and Idiopathic Thrombocytopenic Purpura Bleeding Scale Using LUNA 3 Phase 3 Trial Data
Sep 9, 2025, 16:22 PM -
Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease
Sep 9, 2025, 16:22 PM
